We are live on ! Find out more
BBNX

Beta Bionics
BBNX

116 hedge funds and large institutions have $659M invested in Beta Bionics in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 13

32% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 28

30% more capital invested

Capital invested by funds: $508M → $659M (+$151M)

14% more funds holding

Funds holding: 102 → 116 (+14)

7.25% more ownership

Funds ownership: 96.2% → 103.45% (+7.2%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
116
Holders Change
+14
Holders Change %
+13.73%
% of All Funds
1.53%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
37
Reduced
28
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$21.9M
2
DSCM
Divisadero Street Capital Management
Florida
+$13.4M
3
FCM
Farallon Capital Management
California
+$12.3M
4
VPC
Vestal Point Capital
New York
+$7.79M
5
Millennium Management
Millennium Management
New York
+$7.68M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$12.8M
2
BlackRock
BlackRock
New York
-$8.05M
3
PVI
Pura Vida Investments
New York
-$6.04M
4
Citadel Advisors
Citadel Advisors
Florida
-$5.75M
5
Holocene Advisors
Holocene Advisors
New York
-$4.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
51
Evanson Asset Management
California
$565K – – –
PWM
52
Palumbo Wealth Management
New York
$431K +$419K +29,579 New
Bank of New York Mellon
53
Bank of New York Mellon
New York
$398K +$22.1K +1,560 +6%
SFM
54
Soros Fund Management
New York
$364K -$13.7K -968 -4%
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$343K +$31.2K +2,205 +10%
Barclays
56
Barclays
United Kingdom
$330K +$74.4K +5,255 +30%
Two Sigma Investments
57
Two Sigma Investments
New York
$310K +$7.71K +545 +3%
Ameriprise
58
Ameriprise
Minnesota
$302K -$471K -33,254 -62%
QCM
59
Quantinno Capital Management
New York
$288K +$280K +19,770 New
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$268K +$78.7K +5,559 +43%
XT
61
XTX Topco
Cayman Islands
$267K +$259K +18,318 New
N
62
Nuveen
North Carolina
$248K – – –
Renaissance Technologies
63
Renaissance Technologies
New York
$240K +$234K +16,500 New
LPL Financial
64
LPL Financial
California
$240K +$66.1K +4,668 +40%
Fidelity Investments
65
Fidelity Investments
Massachusetts
$238K +$134K +9,494 +138%
Invesco
66
Invesco
Georgia
$237K -$2.38K -168 -1%
Susquehanna International Group
67
Susquehanna International Group
Pennsylvania
$226K -$5.49K -388 -2%
Wells Fargo
68
Wells Fargo
California
$219K -$11.3K -800 -5%
CC
69
Centiva Capital
New York
$212K -$79.1K -5,585 -28%
GIA
70
Gladstone Institutional Advisory
Florida
$207K +$201K +14,200 New
Deutsche Bank
71
Deutsche Bank
Germany
$199K +$22.4K +1,580 +13%
MIM
72
MetLife Investment Management
New Jersey
$122K – – –
Mirae Asset Global ETFs Holdings
73
Mirae Asset Global ETFs Holdings
Hong Kong
$109K -$4.42K -312 -4%
JP Morgan Chase
74
JP Morgan Chase
New York
$89.8K -$1.27K -90 -1%
SIM
75
Sandia Investment Management
Massachusetts
$87.4K – – –
1 2
3
4 5

BBNX Hedge Fund Activity: Q2 2025 in Review

116 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q2 2025, worth a combined $659M — up 30% from $508M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new BBNX positions and 13 closed out — a net gain of 15 holders — while 37 added to existing stakes and 28 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $21.9M. The largest seller was AllianceBernstein, cutting an estimated $12.8M.

  • 116 institutional investors held Beta Bionics (BBNX) as of Q2 2025, up from 102 in Q1 2025.
  • Funds reported $659M of Beta Bionics stock for Q2 2025, up 30% quarter-over-quarter.
  • 28 funds opened new Beta Bionics positions in Q2 2025 and 13 closed out, a net change of +15 holders.
  • The largest Beta Bionics buyer in Q2 2025 was Morgan Stanley, an estimated $21.9M added.
  • The largest Beta Bionics seller in Q2 2025 was AllianceBernstein, an estimated $12.8M sold.

Based on aggregated 13F filings for Q2 2025.